ACM
GILD icon

Atlanta Capital Management’s Gilead Sciences GILD Stock Holding History

Atlanta Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-216,539
Closed -$15.3M – 155
2017
Q2 		$15.3M Sell
216,539
-8,347
-4% -$555K 0.09% 135
2017
Q1 		$15.3M Sell
224,886
-389,652
-63% -$27.4M 0.09% 144
2016
Q4 		$44M Sell
614,538
-44,433
-7% -$3.3M 0.28% 87
2016
Q3 		$52.1M Sell
658,971
-76,458
-10% -$6.21M 0.35% 77
2016
Q2 		$61.3M Buy
735,429
+29,980
+4% +$2.66M 0.41% 74
2016
Q1 		$64.8M Buy
705,449
+45,581
+7% +$4.11M 0.46% 70
2015
Q4 		$66.8M Sell
659,868
-100,688
-13% -$10.5M 0.49% 69
2015
Q3 		$74.7M Sell
760,556
-487,153
-39% -$54.1M 0.56% 73
2015
Q2 		$146M Sell
1,247,709
-849,793
-41% -$92.9M 0.99% 33
2015
Q1 		$206M Buy
2,097,502
+73,274
+4% +$7.44M 1.4% 17
2014
Q4 		$191M Sell
2,024,228
-201,204
-9% -$20.8M 1.31% 20
2014
Q3 		$237M Sell
2,225,432
-331,396
-13% -$32.4M 1.7% 8
2014
Q2 		$212M Sell
2,556,828
-26,798
-1% -$2.09M 1.45% 16
2014
Q1 		$183M Sell
2,583,626
-123,116
-5% -$9.66M 1.26% 22
2013
Q4 		$203M Sell
2,706,742
-113,236
-4% -$7.88M 1.33% 17
2013
Q3 		$177M Sell
2,819,978
-76,500
-3% -$4.57M 1.26% 21
2013
Q2 		$148M Buy
+2,896,478
New +$151M 1.13% 27

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Atlanta Capital Management's GILD Position: Q3 2017 in Review

Atlanta Capital Management sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 216,539 shares — an estimated $15.3M sold.

Atlanta Capital Management first reported a position in GILD in Q2 2013 and held it in 17 quarters. The position peaked at $237M in Q3 2014. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Atlanta Capital Management reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Atlanta Capital Management sold 216,539 Gilead Sciences shares in Q3 2017, an estimated $15.3M.
  • Atlanta Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 17 quarters.
  • Atlanta Capital Management's Gilead Sciences position peaked at $237M in Q3 2014.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Atlanta Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.